These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Listed as ongoing, but also has a completion date 2005-000217-35 EpSSG RMS 2005 a protocol for non metastatic rhabdomyosarcoma 2016-12-31 bad-data
Ongoing 2005-000855-14 Multicenter, not controlled, prospectic clinical phase IV study: safety and efficacy of an immunosuppressive regimen with Thymoglobuline and Rapamune in patients receiving a renal transplantation from... not-yet-due
Listed as ongoing, but also has a completion date 2005-001139-31 A protocol for localized non rhabdomyosarcoma Soft Tissue Sarcomas, in paediatric age protocollo di studio per sarcomi dei tessuti molli localizzati, non rabdomiosarcomi, in eta' pediatrica 2019-03-11 bad-data
Ongoing 2006-005014-13 The vasoconstrictor drugs in the treatment of the Hepatorenal syndrome. The randomized clinic end multicentric study. not-yet-due
Ongoing 2007-001418-17 efficacy of treatment with bevacizumab,in the macular degeneration. not-yet-due
Ongoing 2007-001430-14 Peg-filgrastim Vs filgrastrim in pediatric patients. not-yet-due
Ongoing 2007-005459-41 Study of superficial lynmph nodes whit superparamagnetic contrast and RMN in patient affected by melanoma. not-yet-due
Completed, but no date 2007-005544-24 Sperimental, controlled, randomized single blind study. Sufentanil vs fentanyl in patientes with thoracotomy for pulmonary resection and videolaparoscopic surgery. bad-data
Ongoing 2008-001236-13 Sperimental controlled and randomized in singol blind study. Use of continuous epidural ketamina in patients submitted to toracotomy for pulmonary resection. not-yet-due
Ongoing 2008-003224-31 EFFECT OF SURFACTANT IN the CINETIC AND INFLAMMATION IN the NEW-BORN PRETERM WHIT RDS SINDROM. not-yet-due
Exempt 2008-005773-35 AUTOLOUGUS STEM CELLS TRANSPLANTATION AFTER LINFOCYTE DEPLETION AS A NEW THERAPY FOR THE AGGRESSIVE AND DRUG RESISTANT FORMS OF MULTIPLE SLEROSIS IN THE ADULTS AND CHILDREN. TRAPIANTO DI CELLULE ST... not-yet-due
Ongoing 2009-010807-10 Study on spinal anestesiology whitbupivacaine, levobupivacaine e ropivacaine. not-yet-due
Ongoing 2009-016176-78 Terapy with everolimus in liver transplant. not-yet-due
Ongoing 2010-022558-18 A pilot trial with clenbuterol in spinal and bulbar muscular atrophy (SBMA). Studio pilota con il clenbuterolo nella atrofia muscolare spinale bulbare (SBMA) not-yet-due
Other 2010-023744-33 Duchenne muscular dystrophy: double-blind randomized trial to find optimum steroid regimen not-yet-due
Completed, but no date Terminated 2011-001995-20 A pilot study on educational aproach to improve compliance to medical precriptions in transplantation recipients. Progetto Pilota d'Intervento Educativo per Migliorare l'Aderenza alle Prescrizioni ... bad-data
Ongoing 2011-002219-28 Effect of pharmacological prophylaxis with low molecular weight heparin on implantation in women undergoing assisted reproductive procedures to prevent implant failure: a prospective randomized study.... not-yet-due
Ongoing 2013-004575-13 A prospective, randomized clinical trial comparing Rivaroxaban vs warfarin in high risk patients with antiphospholipid syndrome (TRAPS). Studio clinico prospettico, randomizzato di confronto tra Ri... not-yet-due
Ongoing 2013-004955-19 PARACETAMOL VERSUS IBUPROFEN FOR PATENT DUCTUS ARTERIOSUS TREATMENT IN PRETERM INFANTS. PARACETAMOLO VERSUS IBUPROFENE PER IL TRATTAMENTO DEL DOTTO DI BOTALLO PERVIO NEL NEONATO PRETERMINE: Stud... not-yet-due
Ongoing 2014-000453-37 Sequential treatment with nucleotide analogue and peg-interferon in patients with HBV-related chronic hepatitis. TRATTAMENTO SEQUENZIALE CON ANALOGO NUCLEOTIDICO E PEG-INTERFERONE IN PAZIENTI CON E... not-yet-due
Ongoing 2014-005052-25 Total versus corrected body weight for dosage of sugammadex in morbidly obese patients. Peso corporeo corretto versus peso corporeo totale per il dosaggio del sugammadex in pazienti con obesità pat... not-yet-due
Ongoing 2014-005116-41 Postoperative pulmonary function in patients undergoing laparoscopic sleeve gastrectomy after administration of sugammadex and neostigmine. A double-blind, randomized controlled trial. La funzione ... not-yet-due
Ongoing 2014-005388-34 Single arm prospective clinical study to evaluate the efficacy of combination therapy sofosbuvir+ribavirin+peg-interferon in experienced patients with HCV-GT1 Studio clinico prospettico a braccio... not-yet-due
No trial status on register 2015-000386-31 Role of SAMITAL in pediatric age ¿ a feasibility study in children with/or at risk of oral mucositis due to chemotherapy and/or radiotherapy Ruolo di SAMITAL¿ in et¿ pediatrica ¿ studio di fattibil... bad-data
Other 2016-000189-45 ADJUVANT TREATMENT FOR HIGH-RISK TRIPLE NEGATIVE BREAST CANCER PATIENTS WITH THE ANTI-PD-L1 ANTIBODY AVELUMAB: A PHASE III RANDOMIZED TRIAL. Studio randomizzato di fase III sull’utilizzo dell’antic... not-yet-due
Ongoing 2016-004034-14 Randomized controlled phase IIb-III clinical trial to assess the effectiveness of different regimens with u-FSH in the infertile male Studio clinico randomizzato controllato di fase IIb-III per val... not-yet-due
Completed, but no date 2016-004665-10 THE GIADA TRIAL. ENGAGING THE IMMUNE SYSTEM TO IMPROVE THE EFFICACY OF NEOADJUVANT CHEMO-ENDOCRINE THERAPY FOR PREMENOPAUSAL LUMINAL B BREAST CANCER PATIENTS. THE GIADA TRIAL. ENGAGING THE IMMUNE S... bad-data
Ongoing 2017-005103-27 A PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CLENBUTEROL IN PATIENTS WITH SPINAL AND BULBAR MUSCULAR ATROPHY (SBMA) TRIAL CLINICO CONTROLLATO CON PLACEBO PER VALUTARE EFFICACIA... not-yet-due
Ongoing 2019-004019-29 Medical combination therapy with retinoic acid and cabergoline in ACTH-secreting pituitary adenoma: a prospective and randomized study. Studio prospettico randomizzato multicentrico sull’efficacia ... not-yet-due
Not reported Terminated 2020-002570-27 A Randomized Clinical Trial of Nafamostat: A Potent Transmembrane Protease Serine 2 (TMPRSS2) Inhibitor for the Treatment of Covid-19 Trial Clinico Randomizzato con Nafamostat: un potente inibitore... 2022-08-01 due-trials